Catherine Lesage

Ipsen
Papers:
FP27-2 Population Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis of Lanreotide Depot in Acromegalic Patients: Clinical Evidence for a 8-week Extended Dosing Interval (EDI)